Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,008 | 80,213 | 73,189 | 53,002 | 66,428 |
| Marketable Securities | 337,775 | 317,784 | 278,619 | 262,131 | 246,473 |
| Receivables | 49,175 | 41,454 | 30,728 | 40,091 | 40,350 |
| Inventories | 46,410 | 45,690 | 44,793 | 46,503 | 46,195 |
| Other current assets | 1,757 | 1,080 | 301 | 665 | 781 |
| TOTAL | $480,244 | $491,967 | $438,737 | $408,970 | $405,762 |
| Non-Current Assets | |||||
| PPE Net | 1,986 | 2,111 | 2,266 | 2,421 | 2,576 |
| Intangibles | 3,590 | 3,761 | 3,901 | 4,046 | 4,158 |
| Other Non-Current Assets | 238,177 | 253,748 | 82,624 | 87,125 | 92,354 |
| TOTAL | $243,753 | $259,620 | $88,791 | $93,592 | $99,088 |
| Total Assets | $723,997 | $751,587 | $527,528 | $502,562 | $504,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,661 | 3,313 | 2,214 | 3,312 | 4,220 |
| Accrued Expenses | 58,196 | 66,621 | 49,536 | 49,704 | 42,353 |
| Other current liabilities | 2,522 | 2,480 | 2,502 | 2,537 | 1,695 |
| TOTAL | $86,556 | $93,724 | $76,220 | $78,266 | $68,406 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,036 | 3,720 | 4,602 | 5,499 | 4,594 |
| Other Non-Current Liabilities | 9,221 | 11,562 | 17,561 | 17,364 | 16,976 |
| TOTAL | $69,815 | $76,532 | $85,537 | $88,995 | $86,254 |
| Total Liabilities | $156,371 | $170,256 | $161,757 | $167,261 | $154,660 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,602 | 132,971 | 131,841 | 131,630 | 135,104 |
| Common Shares | 1,086,650 | 1,120,035 | 1,116,797 | 1,122,582 | 1,163,262 |
| Retained earnings | -615,013 | -649,368 | -860,162 | -891,713 | -913,226 |
| Other shareholders' equity | -880 | -599 | -749 | -905 | -825 |
| TOTAL | $567,626 | $581,331 | $365,771 | $335,301 | $350,190 |
| Total Liabilities And Equity | $723,997 | $751,587 | $527,528 | $502,562 | $504,850 |